Recent Finacing
Recent Raise
Agensys develops monoclonal antibodies and antibody‑drug conjugates targeting tumor-specific surface proteins (e.g., PSCA), advancing candidates like AGS-PSCA through early clinical trials with industry partners.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
